DK236185D0 - Stabiliseret insulin-formulering - Google Patents

Stabiliseret insulin-formulering

Info

Publication number
DK236185D0
DK236185D0 DK236185A DK236185A DK236185D0 DK 236185 D0 DK236185 D0 DK 236185D0 DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 D0 DK236185 D0 DK 236185D0
Authority
DK
Denmark
Prior art keywords
insulin formulation
stabilized insulin
stabilized
formulation
insulin
Prior art date
Application number
DK236185A
Other languages
English (en)
Other versions
DK236185A (da
Inventor
Eddie Herman Massey
Theodore Arsay Sheliga
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK236185D0 publication Critical patent/DK236185D0/da
Publication of DK236185A publication Critical patent/DK236185A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK236185A 1984-05-29 1985-05-28 Stabiliseret insulin-formulering DK236185A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61435584A 1984-05-29 1984-05-29

Publications (2)

Publication Number Publication Date
DK236185D0 true DK236185D0 (da) 1985-05-28
DK236185A DK236185A (da) 1985-11-30

Family

ID=24460897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236185A DK236185A (da) 1984-05-29 1985-05-28 Stabiliseret insulin-formulering

Country Status (5)

Country Link
EP (1) EP0166529B1 (da)
JP (1) JPS6122026A (da)
CA (1) CA1244347A (da)
DE (1) DE3576458D1 (da)
DK (1) DK236185A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0200383A3 (en) * 1985-04-15 1987-09-02 Eli Lilly And Company An improved method for administering insulin
BR8603586A (pt) * 1985-07-30 1987-03-10 Int Minerals & Chem Corp Processo para manter a fluidez de um homonio;processo para efetuar a promocao de crescimento em animais e formulacao promotora de crescimento
US5889153A (en) * 1994-05-20 1999-03-30 Hisamitsu Pharmaceutical Co., Inc. Protein or polypeptide, method for producing the same and intermediate compound therefor
US5968899A (en) * 1994-06-03 1999-10-19 Tsumura & Co. Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
FR2755440B1 (fr) * 1996-11-07 1999-01-15 Tuffet Sophie Procede de conservation de longue duree de molecules d'adn et conditionnement pour sa mise en oeuvre
PL191861B1 (pl) * 1998-05-06 2006-07-31 Jacques Bonnet Sposób długoterminowej konserwacji cząsteczek DNA i opakowanie konserwujące
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
DK2498802T3 (da) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Farmaceutisk præparat omfattende en glp-1-agonist, et insulin og en methionin
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
ZA808097B (en) * 1980-12-29 1982-01-27 Lilly Co Eli Novel insulin formulations

Also Published As

Publication number Publication date
EP0166529A1 (en) 1986-01-02
JPS6122026A (ja) 1986-01-30
EP0166529B1 (en) 1990-03-14
CA1244347A (en) 1988-11-08
DK236185A (da) 1985-11-30
DE3576458D1 (de) 1990-04-19

Similar Documents

Publication Publication Date Title
BR8806982A (pt) Composicao estabilizada
BR8802017A (pt) Composicao estabilizada
NO2000005I1 (no) Insulin aspart
DK479685A (da) Stol
DK481585A (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
MX163529B (es) Composicion quimicoluminiscente
DK236185A (da) Stabiliseret insulin-formulering
FR2590799B1 (fr) Seringue
DK162562C (da) Staldkonstruktion
IT1209615B (it) Composizione farmaceutica
DK86785A (da) Bromcryptinpraeparater
DK182287A (da) Stabiliserede peptidsoedemidler
MX163537B (es) Composicion insecticida
FR2582908B3 (fr) Compositions stabilisees.
ES288629Y (es) Jeringa
DK51885A (da) Glycosylerede insulinderivater
KR860007343U (ko) 주사용 수액세트
ES276839Y (es) Jeringuilla
BR8406387A (pt) Seringa
IT8454191U1 (it) Siringa di applicazione medico-veterinaria
SE8402858D0 (sv) Ampull
SE8400444D0 (sv) Ateranvendningsbart bodunderlag
DK42483D0 (da) Stabiliserede insulinoploesninger
RO90654A2 (ro) Compozitie insecticida sinergetica
RO92144A2 (ro) Compozitie insecticida

Legal Events

Date Code Title Description
ATS Application withdrawn